http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-034813-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8b6cf96de4019dcab870c78b0ae385b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-21 |
| filingDate | 2016-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3481e6f00a5a7b337788f56960ae62bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51b4d39c858e843587ba33ca789a2cc2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48523466e3e069ade424900d9a58d5cd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c288014dccc8cf9c84b94a09bd44150 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_656c1347ad49e7e85872d631c85df03b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c3b4c0feaf562124ddeb3c800f49277 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80a99625303423bfd46d2e25cc37fafe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5422cff29e772324056a9f0c9bfddf43 |
| publicationDate | 2020-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-034813-B1 |
| titleOfInvention | HUMAN IMMUNO DEFICIENCY STRAIN I-TYPE IV748 SUBTYPE A FOR DIAGNOSTIC AND VACCINE DRUGS |
| abstract | The invention relates to the field of virology and biotechnology and can be used to obtain diagnostic and experimental vaccine preparations. A new strain of the human immunodeficiency virus IV748 is described, isolated on the territory of the Russian Federation from a patient who did not receive ARV therapy; the route of infection is sexual (heterosexual contact). Belongs to the HIV subtype A variant, which is currently circulating in most of the Russian Federation. Genetic analysis of the nucleotide sequences of the reverse transcriptase gene, protease gene, and integrase gene, carried out using the AmpliSens HIV-Resist-Seq reagent kit, showed that this strain of the virus belongs to subtype A and does not contain resistance mutations to antiretroviral drugs. It has stable reproductive activity. The infectious titer is 6 lg TCD 50. It is proposed for use as a physiologically acceptable means for the effective and high-precision study of the antiviral effect of new generation chemotherapeutic agents and for the development of a vaccine. |
| priorityDate | 2016-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 130.